一株表皮葡萄球菌菌株SI-BP-02及其在抗菌中的应用
By screening and isolating Staphylococcus epidermidis strain SI-BP-02, the problem of bacterial resistance caused by existing antibiotic treatments has been solved, providing an effective means of inhibiting various drug-resistant microorganisms and achieving broad-spectrum antibacterial activity against drug-resistant bacteria.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HEFEI INSTITUTE OF PHYSICAL SCIENCE CHINESE ACADEMY OF SCIENCES
- Filing Date
- 2023-06-09
- Publication Date
- 2026-07-17
AI Technical Summary
Current antibiotic treatments lead to increased bacterial resistance, and there is a lack of effective means to combat multiple drug-resistant bacteria, making it difficult to cope with the threat of bacterial infections.
A Staphylococcus epidermidis strain, SI-BP-02, was screened and isolated. This strain exhibits antagonistic activity against a variety of drug-resistant and non-drug-resistant microorganisms and secretes broad-spectrum antibacterial substances, which can be used to prepare antibacterial agents.
This strain exhibits significant antibacterial activity against a variety of drug-resistant microorganisms, such as ESBLs-Escherichia coli, CRE-Escherichia coli, and MRSA, maintaining microbiome homeostasis and providing an effective means of combating drug-resistant bacteria.
Smart Images
Figure CN116875486B_ABST